124 related articles for article (PubMed ID: 15254688)
1. Isolation of LEM domain-containing 1, a novel testis-specific gene expressed in colorectal cancers.
Yuki D; Lin YM; Fujii Y; Nakamura Y; Furukawa Y
Oncol Rep; 2004 Aug; 12(2):275-80. PubMed ID: 15254688
[TBL] [Abstract][Full Text] [Related]
2. Relationship between intron 4b splicing of the rat geranylgeranyl diphosphate synthase gene and the active enzyme expression level.
Matsumura Y; Kuzuguchi T; Sagami H
J Biochem; 2004 Sep; 136(3):301-12. PubMed ID: 15598886
[TBL] [Abstract][Full Text] [Related]
3. Infrequent and low expression of cancer-testis antigens located on the X chromosome in colorectal cancer: implications for immunotherapy in South African populations.
Dakshinamurthy AG; Ramesar R; Goldberg P; Blackburn JM
Biotechnol J; 2008 Nov; 3(11):1417-23. PubMed ID: 18956367
[TBL] [Abstract][Full Text] [Related]
4. Efficient identification of a novel cancer/testis antigen for immunotherapy using three-step microarray analysis.
Yokoe T; Tanaka F; Mimori K; Inoue H; Ohmachi T; Kusunoki M; Mori M
Cancer Res; 2008 Feb; 68(4):1074-82. PubMed ID: 18281482
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel tumor-associated antigen, cadherin 3/P-cadherin, as a possible target for immunotherapy of pancreatic, gastric, and colorectal cancers.
Imai K; Hirata S; Irie A; Senju S; Ikuta Y; Yokomine K; Harao M; Inoue M; Tsunoda T; Nakatsuru S; Nakagawa H; Nakamura Y; Baba H; Nishimura Y
Clin Cancer Res; 2008 Oct; 14(20):6487-95. PubMed ID: 18927288
[TBL] [Abstract][Full Text] [Related]
6. Molecular cloning and characterization of a novel human BTB domain-containing gene, BTBD10, which is down-regulated in glioma.
Chen J; Xu J; Ying K; Cao G; Hu G; Wang L; Luo C; Lou M; Mao Y; Xie Y; Lu Y
Gene; 2004 Sep; 340(1):61-9. PubMed ID: 15556295
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel prostate cancer-associated tumor antigen.
Miles AK; Rogers A; Li G; Seth R; Powe D; McArdle SE; McCulloch TA; Bishop MC; Rees RC
Prostate; 2007 Feb; 67(3):274-87. PubMed ID: 17192878
[TBL] [Abstract][Full Text] [Related]
8. Identification of TOMM34, which shows elevated expression in the majority of human colon cancers, as a novel drug target.
Shimokawa T; Matsushima S; Tsunoda T; Tahara H; Nakamura Y; Furukawa Y
Int J Oncol; 2006 Aug; 29(2):381-6. PubMed ID: 16820880
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer.
Seiden-Long IM; Brown KR; Shih W; Wigle DA; Radulovich N; Jurisica I; Tsao MS
Oncogene; 2006 Jan; 25(1):91-102. PubMed ID: 16158056
[TBL] [Abstract][Full Text] [Related]
10. Expression of cancer testis genes in human brain tumors.
Sahin U; Koslowski M; Türeci O; Eberle T; Zwick C; Romeike B; Moringlane JR; Schwechheimer K; Feiden W; Pfreundschuh M
Clin Cancer Res; 2000 Oct; 6(10):3916-22. PubMed ID: 11051238
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of a novel human gene, VANGL1, as a therapeutic target for hepatocellular carcinoma.
Yagyu R; Hamamoto R; Furukawa Y; Okabe H; Yamamura T; Nakamura Y
Int J Oncol; 2002 Jun; 20(6):1173-8. PubMed ID: 12011995
[TBL] [Abstract][Full Text] [Related]
12. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer.
Garg M; Chaurasiya D; Rana R; Jagadish N; Kanojia D; Dudha N; Kamran N; Salhan S; Bhatnagar A; Suri S; Gupta A; Suri A
Clin Cancer Res; 2007 Mar; 13(5):1421-8. PubMed ID: 17332284
[TBL] [Abstract][Full Text] [Related]
13. The septin-binding protein anillin is overexpressed in diverse human tumors.
Hall PA; Todd CB; Hyland PL; McDade SS; Grabsch H; Dattani M; Hillan KJ; Russell SE
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6780-6. PubMed ID: 16203764
[TBL] [Abstract][Full Text] [Related]
14. Identification of cancer/testis-antigen genes by massively parallel signature sequencing.
Chen YT; Scanlan MJ; Venditti CA; Chua R; Theiler G; Stevenson BJ; Iseli C; Gure AO; Vasicek T; Strausberg RL; Jongeneel CV; Old LJ; Simpson AJ
Proc Natl Acad Sci U S A; 2005 May; 102(22):7940-5. PubMed ID: 15905330
[TBL] [Abstract][Full Text] [Related]
15. A novel cancer testis antigen that is frequently expressed in pancreatic, lung, and endometrial cancers.
Okada T; Akada M; Fujita T; Iwata T; Goto Y; Kido K; Okada T; Matsuzaki Y; Kobayashi K; Matsuno S; Sunamura M; Kawakami Y
Clin Cancer Res; 2006 Jan; 12(1):191-7. PubMed ID: 16397042
[TBL] [Abstract][Full Text] [Related]
16. Molecular cloning and expression of a novel alternative splice variant of BRDT gene.
Zheng Y; Yuan W; Zhou Z; Xu M; Sha JH
Int J Mol Med; 2005 Feb; 15(2):315-21. PubMed ID: 15647849
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel human cancer/testis antigen, KM-HN-1, recognized by cellular and humoral immune responses.
Monji M; Nakatsura T; Senju S; Yoshitake Y; Sawatsubashi M; Shinohara M; Kageshita T; Ono T; Inokuchi A; Nishimura Y
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6047-57. PubMed ID: 15447989
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of gene expression by cDNA microarray in human colorectal cancer tissues and normal mucosa.
Bianchini M; Levy E; Zucchini C; Pinski V; Macagno C; De Sanctis P; Valvassori L; Carinci P; Mordoh J
Int J Oncol; 2006 Jul; 29(1):83-94. PubMed ID: 16773188
[TBL] [Abstract][Full Text] [Related]
19. Identification of secernin 1 as a novel immunotherapy target for gastric cancer using the expression profiles of cDNA microarray.
Suda T; Tsunoda T; Uchida N; Watanabe T; Hasegawa S; Satoh S; Ohgi S; Furukawa Y; Nakamura Y; Tahara H
Cancer Sci; 2006 May; 97(5):411-9. PubMed ID: 16630140
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel cancer-testis antigen CRT2 frequently expressed in various cancers using representational differential analysis.
Hayashi E; Matsuzaki Y; Hasegawa G; Yaguchi T; Kurihara S; Fujita T; Kageshita T; Sano M; Kawakami Y
Clin Cancer Res; 2007 Nov; 13(21):6267-74. PubMed ID: 17975137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
